Abstract:An amino‐functionalization strategy is introduced to fabricate a library of kidney‐targeting fluorophores NHcy with tunable emission ranging from NIR‐I to NIR‐II. Building on this NIR‐II kidney‐targeting platform, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after tail intravenous injection and achieves precise visualization of metabolic acidosis induced by cisplatin and renal I/R injury. The development of rapidly distributed and retained probes within the kidneys is important for accurately diagnosing kidney diseases. Although molecular imaging shows the potential for non‐intrusively interrogating kidney disease‐related biomarkers, the limited kidney contrast of many fluorophores, owing to their relatively low distribution in the kidney, hinders their effectiveness for kidney disease detection. Herein, for the first time, an amino‐functionalization strategy is proposed to construct a library of kidney‐targeting fluorophores NHcy with tunable emissions from NIR‐I to NIR‐II. Among these, NHcy‐8 is the first small‐molecule NIR‐II dye without a renal clearance moiety, designed specifically for kidney‐targeting imaging. Building on this class of NIR‐II fluorophore, the first NIR‐II small‐molecule kidney‐targeting pH probe NIR‐II‐pH is developed, which exhibits a desirable kidney distribution after intravenous injection and is fluorescent only after activation by acidosis. NIR‐II in vivo fluorescence/photoacoustic imaging of kidney disease models induced by cisplatin and renal I/R injury using NIR‐II‐pH reveals increasingly severe metabolic acidosis as the disease progressed, enabling sensitive detection of the onset of acidosis 36 h (cisplatin group) earlier than clinical methods. Thus, this study introduces a practical NIR‐II kidney‐targeting probe and provides a useful molecular blueprint for guiding kidney‐targeting NIR‐II fluorophores as diagnostic aids for kidney diseases.

Renal clearable polyfluorophore nanosensors for early diagnosis of cancer and allograft rejection

Renal clearable catalytic gold nanoclusters for in vivo disease monitoring

Renal-clearable Nanoprobes for Optical Imaging and Early Diagnosis of Diseases

Point-of-care non-invasive enzyme-cleavable nanosensors for acute transplant rejection detection

Renal Clearable Magnetic Nanoreporter for Colorimetric Urinalysis of Tumor

Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection

Recent Advances in Renal Clearable Inorganic Nanoparticles for Cancer Diagnosis

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

High‐contrast Noninvasive Imaging of Kidney Clearance Kinetics Enabled by Renal Clearable Nanofluorophores

Renal-clearable Macromolecular Reporter for Near-infrared Fluorescence Imaging of Bladder Cancer.

Hypoxia‐Responsive Platinum Supernanoparticles for Urinary Microfluidic Monitoring of Tumors

Combined Ultrasensitive Detection of Renal Cancer Proteins and Cells Using an Optical Microfiber Functionalized with Ti3C2 MXene and Gold Nanorod-Nanosensitized Interfaces

Engineering of Kidney‐Targeting Fluorophores with Tunable Emission from NIR‐I to NIR‐II for Early Diagnosis of Kidney Disease

Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-Assembly for Kidney Cancer Diagnosis and Classification

Noninvasive Early Diagnosis of Allograft Rejection by a Granzyme B Protease Responsive NIR‐II Bioimaging Nanosensor

Rapid and non-invasive renal injury diagnosis unlocked by a glimpse into urinary protein particle size and charge

Renal clearing carbon dots-based near-infrared fluorescent super-small nanoprobe for renal imaging

Bright and Renal-Clearable Au Nanoclusters with NIR-II Excitation and Emission for High-Resolution Fluorescence Imaging of Kidney Dysfunction

A Nanosensor for Precise Discrimination of Nephrotoxic Drug Mechanisms Via Dynamic Fluorescence Fingerprint Strategy

Synthesis of Renal-Clearable Multicolor Fluorescent Silicon Nanodots for Tumor Imaging and in Vivo H2O2 Profiling